AI in Healthcare

Today's Stories

1. 1

   Data Aggregation Drives AI's Impact on Clinical Supply Chains, PharmTech Reports

   PharmTech.com published a report titled "Data Aggregation Drives AI's Impact on Clinical Supply Chains." The report frames data aggregation as the driver of AI's effect on clinical supply chains.

   The title points to data aggregation and clinical supply chains as the areas the report addresses.

2. 2

   Sovereign AI push widens as SoftBank, Sony, NEC, Honda set up Noetra

   The article frames Sovereign AI as a response to five systemic risks, including data governed by foreign law and services that can be halted on another government's order. SoftBank, Sony, NEC and Honda are among firms creating a joint venture called Noetra. Japan's approach differs from the US pursuit of ultra-large general models, focusing instead on areas of national strength such as manufacturing, robots and healthcare. A full ecosystem spans five layers from semiconductors to people and operations, per the article.

   The article suggests sovereign AI could shift domestic demand for semiconductors, which has been sluggish as manufacturers moved factories abroad. It also points to the likelihood that company-level sovereignty gains importance, not just national sovereignty.

3. 3

   SSFC partners with Earthbook, Jedsy for medical drone logistics

   Shinkong Synthetic Fibers Corporation (SSFC) is partnering with Earthbook, a Taiwan-based drone-data and AI platform, and Delivery Glider AG (Jedsy), a Swiss medical logistics company, to develop commercial drone services. This marks SSFC's entry into Taiwan's emerging low-altitude economy, with the initial focus on medical logistics rather than other commercial uses.

   The partnership's success hinges on whether these commercial drone services can be established in Taiwan's medical logistics market. No timeline or investment details were disclosed.

4. 4

   Sante scores 83.83 on DiagnosisArena-MCQ, a 4-choice test

   Ant Ling reported 83.83 for Ling-3.0-flash-Sante on DiagnosisArena-MCQ, where the model is given case information, examinations and tests, then chooses among four diagnoses. The number measures answer-selection with the candidate set and evidence already supplied, not generating an unrestricted differential, spotting missing history, or choosing the next investigation — those would need different evaluations.

   The release also cites MedXpertQA-Text 53.88 and HealthBench Professional 45.73; the test is whether such scores translate to open-ended clinical reasoning, which these evals do not cover.

5. 5

   De la Fuente lab uses ChatGPT, Codex to hunt new antibiotics

   Bioengineer César de la Fuente's lab uses ChatGPT and Codex alongside its own deep-learning models to search genomes for antimicrobial candidates, cutting the initial search from years to hours. The lab turns biology into an information system, reading DNA and peptides as an alphabet to find signals across vast datasets, rather than modifying existing antibiotics—a path de la Fuente says has yielded no new antibiotic class in 50 years.

   AI only narrows the candidate list; the test is whether lab validation and years of trials turn any molecule into an approved drug. Watch the projected annual death toll, roughly doubling by 2050.

6. 6

   Taiwan takes smart health push to Medical Fair Asia 2026

   Taiwan's National Science and Technology Council led hospitals and smart health care companies to Singapore for Medical Fair Asia 2026, the region's largest medical device exhibition. The delegation showcased integrated AI, information and communications technology, medical equipment and clinical services, part of a broader effort to expand in southern markets.

   Whether the partnerships pursued at the show translate into southern market expansion hinges on follow-through after the exhibition. The body does not state any deal values or timelines.